Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode
Device Implantable hearing solution
PDI 09321502036580
General payments
$1,869,548
Research payments
$5,494,998
Through program year 2025, $1,869,548 in general payments and $5,494,998 in research payments were reported against Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode (Implantable hearing solution).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $756,648 | 2,118 |
| 2025 | Research | $2,600,648 | 297 |
| 2024 | General | $589,329 | 1,816 |
| 2024 | Research | $1,346,536 | 186 |
| 2023 | General | $347,439 | 1,473 |
| 2023 | Research | $1,387,895 | 206 |
| 2021 | General | $176,133 | 727 |
| 2021 | Research | $159,919 | 20 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 51 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 53 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
6,134 general · 709 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.